5. Conclusion
PRIMARY ALDOSTERONISM
This is the first study on the operational innovation of AVS that demonstrates the effectiveness and safety of simultaneous AVS treatment through the cubital vein and femoral vein, expanding the choice of catheters. The TIG catheter via the femoral vein is an option when the RAV is open towards the third quadrant.Single-center clinical studies, small samples, and existing selection bias are limitations of this study. This report is a preliminary study, and as the number of patients increases, we will conduct a multicenter, large-sample clinical study. In the future, we will include multiple catheters in the trial, such as the SIMON catheter and the VER135° catheter. We hope to increase the success rate of AVS to 100% and provide the gold standard of diagnosis for the treatment of primary aldosteronism.